Radiology Doctors in St. Petersburg, FL Accepting Medicare

4 Radiology doctors found. Showing 1 - 4

Dr. Kit Hanson Clarke, M. D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1501 Pasadena Ave S., St. Petersburg, FL 33707 Phone: 727-381-1000

Dr. Anthony Pascal Garritano, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: Veterans Affairs Medical Center, 10000 Bay Pines Blvd, St. Petersburg, FL 33708 Phone: 727-398-6661    Fax: 727-398-9575

Joanne Cressman, MD Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1200 7th Avenue North, Suite 340, St. Petersburg, FL 33705 Phone: 727-825-1100    Fax: 727-827-5155

Dr. Ronnie S. Pollack, M. D. Radiology - Diagnostic Radiology Medicare: Not Enrolled in Medicare Practice Location: 1501 Pasadena Avenue South, St. Petersburg, FL 33707 Phone: 727-381-1000

News Archive

MRI brain scans may help clinicians decide between CBT and drug treatment for depression

Researchers from Emory University have found that specific patterns of activity on brain scans may help clinicians identify whether psychotherapy or antidepressant medication is more likely to help individual patients recover from depression.

Study looks at the experiences of nurses with euthanasia, other end-of-life decisions

Nurses in Belgium who administer life-ending drugs in euthanasia and in cases without explicit patient request often act outside of the law, according to a study in CMAJ.

Biochemics and Pacific Pharmaceutical to collaborate on skin products

BioChemics, Inc. (BCI) has announced the signing of a research collaboration agreement with Pacific Pharmaceutical Co., Ltd, a publicly held Company in South Korea to evaluate the use of BCI's VALE® based compositions in cosmetic applications.

Savient Pharmaceuticals' total revenues reach $1.1M in first-quarter 2010

Savient Pharmaceuticals, Inc. announced that its board of directors, with input from its financial advisors, has determined that a sale of Savient post-approval of KRYSTEXXA by the U.S. Food and Drug Administration (assuming KRYSTEXXA is approved) would be the best way to realize the full commercial potential of KRYSTEXXA on a global basis and would be the optimal outcome for the Company's shareholders and other stakeholders.

New Focused Update to CCS atrial fibrillation guidelines released

The Canadian Journal of Cardiology has just released the 2016 Focused Update to the Canadian Cardiovascular Society's atrial fibrillation (AF) guidelines.

Read more Medical News

› Verified 1 days ago